OSAKA, Japan & DEERFIELD, Ill. & NEW YORK -- -- Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen.
More...
More...